Clinical Trial Update: Specific Blockage of Angiotensine 2 and Podocyturia in Glomerular Nephropathies With Hypertension and Proteinuria [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating specific blockade of angiotensin II to reduce podocyturia in glomerular nephropathies with hypertension and proteinuria is currently su…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease
• Glomerular Nephropathies
• Hypertension

Drugs mentioned

• Angiotensin II receptor blocker (ARB) (angiotensin II receptor blocker)

Snippet

Sponsor: University Hospital, Strasbourg, France | Conditions: Proteinuria, Hypertension | Phase 4 | Status: SUSPENDED